CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,088,801
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,088,801. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-12-09 | GILL DAVID N Director | Purchase | +5,000 | $1.92 | $10K | 5,000 |
| 2016-12-02 | Lewis Michael Director | Conversion | +996,779 | 3,072,110 | ||
| 2016-12-02 | Lewis Michael Director | Conversion · Series A Convertible Preferred Stock | −2,242.75 | 0 | ||
| 2016-12-02 | Wilmslow Estates Ltd 10% owner | Conversion | +996,779 | 3,072,110 | ||
| 2016-12-02 | Wilmslow Estates Ltd 10% owner | Conversion · Series A Convertible Preferred Stock | −2,242.75 | 0 | ||
| 2016-12-02 | Lieber Jonathan I Chief Financial Officer | Purchase | +5,000 | $1.95 | $10K | 5,000 |
| 2016-12-01 | Gridley Adam President and CEO | Purchase | +5,000 | $2.01 | $10K | 5,000 |
| 2016-11-30 | RAKIN KEVIN Director | Conversion | +26,699 | 112,499 | ||
| 2016-11-30 | RAKIN KEVIN Director | Conversion | +26,699 | 139,198 | ||
| 2016-11-30 | RAKIN KEVIN Director | Conversion | +88,998 | 228,196 | ||
| 2016-11-30 | RAKIN KEVIN Director | Conversion · Series A Convertible Preferred Stock | −60.07 | 0 | ||
| 2016-11-30 | RAKIN KEVIN Director | Conversion · Series A Convertible Preferred Stock | −60.07 | 0 | ||
| 2016-11-30 | RAKIN KEVIN Director | Conversion · Series A Convertible Preferred Stock | −200.25 | 0 | ||
| 2016-09-29 | SPLIT ROCK PARTNERS II, LP 10% owner | Purchase | +276,801 | $2.25 | $623K | 1,661,495 |
| 2016-09-29 | SPLIT ROCK PARTNERS II, LP 10% owner | Purchase · Series A Convertible Preferred Stock | +2,506.6 | $1,000.00 | $2.5M | 2,506.6 |
| 2016-09-29 | SPLIT ROCK PARTNERS II, LP 10% owner | Purchase · Common Stock Warrant (right to buy) | +1,390,844 | 1,390,844 | ||
| 2016-09-29 | RAKIN KEVIN Director | Grant or award | +6,634 | $2.25 | $15K | 57,053 |
| 2016-09-29 | RAKIN KEVIN Director | Grant or award | +6,634 | $2.25 | $15K | 63,687 |
| 2016-09-29 | RAKIN KEVIN Director | Grant or award | +22,113 | $2.25 | $50K | 85,800 |
| 2016-09-29 | RAKIN KEVIN Director | Grant or award · Series A Convertible Preferred Stock | −60.07 | $1,000.00 | $60K | 60.07 |
Page 22 of 27 · 525 trades